Literature DB >> 12824952

Decreased antioxidant activity in hypercholesterolemic children with nephrotic syndrome.

Jacek Zachwieja1, Waldemar Bobkowski, Agnieszka Dobrowolska-Zachwieja, Marcin Zaniew, Janusz Maciejewski.   

Abstract

BACKGROUND: The aim of the present study was to estimate the total antioxidant status (TAS) and main antioxidant enzyme activity in children with nephrotic syndrome (NS). MATERIAL/
METHODS: The study was carried out in a group of 82 children with NS, age 4-16 years (mean 7.4). Of these, 59 with a first episode formed group I, and 23 children in remission (>6 months, with no immunosuppressive treatment) formed group II. TAS was estimated using the two-reagent Randox Total Antioxidant Status test in plasma.
RESULTS: TAS was significantly reduced in group I compared to controls (0.77+/-0.14 mmol/l vs. 1.18+/-0.42 mmol/l; p<0.001). The TAS level was more reduced in those patients with higher total cholesterol (TChol) and low density lipoproteins cholesterol (LDL-cholesterol). In children from group I the activity of glutathione reductase (GR) was lower than in the controls (8.10+/-2.40 U/g Hb vs. 10.55+/-3.81 U/g Hb, p<0.001) and similarly the activity of glutathione peroxidase (GPX) was lower in group I compared to controls (28.65+/-6.99 U/g Hb vs. 33.84+/-13.11 U/g Hb, p=0.010). There was no significant difference in superoxide dismutase (SOD) activity between the 3 groups.
CONCLUSIONS: Reduced antioxidant activity may be related to lipid abnormalities in NS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12824952

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  7 in total

1.  Blood concentration of aminothiols in children with relapse of nephrotic syndrome.

Authors:  Marcin Tkaczyk; Monika Miklaszewska; Jolanta Lukamowicz; Wojciech Fendler
Journal:  World J Pediatr       Date:  2016-06-29       Impact factor: 2.764

2.  Serum malondialdehyde levels, myeloperoxidase and catalase activities in patients with nephrotic syndrome.

Authors:  Huseyin Begenik; Yasemin Usul Soyoral; Reha Erkoc; Habib Emre; Abdullah Taskın; Mehmet Tasdemir; Mehmet Aslan
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

3.  Evaluation of certain constituents of antioxidant defense in youth treated in the past for steroid-sensitive idiopathic nephrotic syndrome.

Authors:  Maria Hanna Kniazewska; Anna Karolina Obuchowicz; Tomasz Wielkoszyński; Joanna Zmudzińska-Kitczak; Katarzyna Urban; Lidia Hyla-Klekot
Journal:  Pediatr Nephrol       Date:  2009-07-28       Impact factor: 3.714

4.  Oxidant stress in primary nephrotic syndrome: does it modulate the response to corticosteroids?

Authors:  Ashraf Bakr; Sami Abul Hassan; Mohamed Shoker; Mayssa Zaki; Rasha Hassan
Journal:  Pediatr Nephrol       Date:  2009-07-31       Impact factor: 3.714

5.  Role of reactive oxygen species in pathogenesis of nephrotic syndrome.

Authors:  Santoshi R Ghodake; A N Suryakar; R D Ankush; K Shaikh; A V Katta
Journal:  Indian J Clin Biochem       Date:  2010-02-10

6.  Correlation between Oxidative Stress and Thyroid Function in Patients with Nephrotic Syndrome.

Authors:  Sangita U Sawant; Subhash Chandran; Alan F Almeida; M G R Rajan
Journal:  Int J Nephrol       Date:  2011-10-13

7.  Role of free radicals and antioxidant status in childhood nephrotic syndrome.

Authors:  S R Ghodake; A N Suryakar; R D Ankush; R V Katkam; K Shaikh; A V Katta
Journal:  Indian J Nephrol       Date:  2011-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.